journal article·2011-08

Analytical characterization of gold nanoparticle primary particles, aggregates, agglomerates, and agglomerated aggregates

Athena M. Keene, Katherine M. Tyner

Journal of Nanoparticle Research· Volume 13· Issue 8
Publisher page

Abstract

Gold nanoparticles have been studied for many biomedical applications. However, alterations in the gold nanoparticles’ environment frequently lead to the formation of aggregates and agglomerates, which have not been well characterized. These new structures could significantly change the biological impact of the nanoparticles, so the appropriate characterization of these structures prior to biological administration is vital for the correct interpretation of toxicology results. By varying the solvent or heating under pressure, four reproducible gold nanoparticles structures were created: 10 nm primary particles, aggregates of the primary particles that contain non-reversible bonds between the individual nanoparticles, agglomerates of primary particles that contain reversible interactions between the individual nanoparticles, and agglomerated aggregates that have reversible bonds linking individual aggregates. Ultraviolet–visible (UV–Vis) spectroscopy, thermal gravitational analysis, and neutron activation analysis were each found to accurately measure the concentration of the primary particles. The primary particles measured 10 nm by dynamic light scattering (DLS) and had a spherical morphology by transmission electron microscopy (TEM) while the aggregates measured 110 nm by DLS and had a distorted morphology by TEM. The agglomerate and aggregated agglomerate samples both measured >1,000 nm by DLS, but the individual particles had significantly different morphologies by TEM. Multiple other analytical techniques, including ultracentrifugation, gel electrophoresis, and X-ray diffraction, also showed unique traits for each structure. The structural differences did not change in the presence of cell culture media or rat serum. In addition, the primary particles, aggregates, and agglomerates each had a unique UV–Vis spectrum, allowing for an inexpensive, rapid method to differentiate between the structures.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Calabretta M, Jamison JA, Falkner JC, Liu Y, Yuhas BD, Matthews KS, Colvin VL (2005) Analytical ultracentrifugation for characterizing nanocrystals and their bioconjugates. Nano Lett 5:963–96710.1021/nl047926f ↗
2. Cho K, Lee Y, Lee CH, Lee K, Kim Y, Choi H, Ryu PD, Lee SY, Joo SW (2008) Selective aggregation mechanism of unmodified gold nanoparticles in detection of single nucleotide polymorphism. J Phys Chem C 112:8629–863310.1021/jp801078m ↗
3. Coccini T, Roda E, Sarigiannis DA, Mustarelli P, Quartarone E, Profumo A, Manzo L (2010) Effects of water-soluble functionalized multi-walled carbon nanotubes examined by different cytotoxicity methods in human astrocyte D384 and lung A549 cells. Toxicology 261:41–5310.1016/j.tox.2010.01.005 ↗
4. Daniel MC, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104:293–34610.1021/cr030698+ ↗
5. Dash P, Scott RW (2009) 1-Methylimidazole stabilization of gold nanoparticles in imidazolium ionic liquids. Chem Commun 812–81410.1039/b816446k ↗
6. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–191910.1016/j.biomaterials.2007.12.037 ↗
7. Demers LM, Mirkin CA, Mucic RC, Reynolds RA III, Letsinger RL, Elghanian R, Viswanadham G (2000) A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. Anal Chem 72:5535–554110.1021/ac0006627 ↗
8. Goel R, Shah N, Visaria R, Paciotti GF, Bischof JC (2009) Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine 4:401–41010.2217/nnm.09.21 ↗
9. Guarise C, Pasquato L, Scrimin P (2005) Reversible aggregation/deaggregation of gold nanoparticles induced by a cleavable dithiol linker. Langmuir 21:5537–554110.1021/la0470232 ↗
10. Haiss W, Thanh NT, Aveyard J, Fernig DG (2007) Determination of size and concentration of gold nanoparticles from UV–vis spectra. Anal Chem 79:4215–422110.1021/ac0702084 ↗
11. Ispas C, Andreescu D, Patel A, Goia DV, Andreescu S, Wallace KN (2009) Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ Sci Technol 43:6349–635610.1021/es9010543 ↗
12. Jans H, Liu X, Austin L, Maes G, Huo Q (2009) Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies. Anal Chem 81:9425–943210.1021/ac901822w ↗
13. Labande A, Ruiz J, Astruc D (2002) Supramolecular gold nanoparticles for the redox recognition of oxoanions: syntheses, titrations, stereoelectronic effects, and selectivity. J Am Chem Soc 124:1782–178910.1021/ja017015x ↗
14. Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, Douglas JF (2010) Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4:365–37910.1021/nn9011187 ↗
15. Lee S, Perez-Luna VH (2007) Surface-grafted hybrid material consisting of gold nanoparticles and dextran exhibits mobility and reversible aggregation on a surface. Langmuir 23:5097–509910.1021/la0629431 ↗
16. Li P, Li D, Zhang L, Li G, Wang E (2008) Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells. Biomaterials 29:3617–362410.1016/j.biomaterials.2008.05.020 ↗
17. Liu MH, Chan CH, Ling JH, Wang CRC (2007a) Filling in dentinal tubules. Nanotechnology 18:47510410.1088/0957-4484/18/47/475104 ↗
18. Liu X, Atwater M, Wang J, Huo Q (2007b) Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloids Surf B 58:3–710.1016/j.colsurfb.2006.08.005 ↗
19. Meier H, Lehmann M, Kolb U (2000) Stilbenoid dendrimers. Chemistry 6:2462–246910.1002/1521-3765(20000703)6:13<2462::AID-CHEM2462>3.0.CO;2-A ↗
20. Nakaso K, Shimada M, Okuyuma K, Deppert K (2002) Evaluation of the change in the morphology of gold nanoparticles during sintering. J Aerosol Sci 33:1061–107410.1016/S0021-8502(02)00058-7 ↗
21. Nam J, Won N, Jin H, Chung H, Kim S (2009) pH-Induced aggregation of gold nanoparticles for photothermal cancer therapy. J Am Chem Soc 131:13639–1364510.1021/ja902062j ↗
22. O’Connell MJ, Bachilo SM, Huffman CB, Moore VC, Strano MS, Haroz EH, Rialon KL, Boul PJ, Noon WH, Kittrell C, Ma J, Hauge RH, Weisman RB, Smalley RE (2002) Band gap fluorescence from individual single-walled carbon nanotubes. Science 297:593–59610.1126/science.1072631 ↗
23. Oh E, Susumu K, Goswami R, Mattoussi H (2010) One-phase synthesis of water-soluble gold nanoparticles with control over size and surface functionalities. Langmuir 26:7604–761310.1021/la904438s ↗
24. Pal A, Ghosh SK, Esumi K, Pal T (2004) Reversible generation of gold nanoparticle aggregates with changeable interparticle interactions by UV photoactivation. Langmuir 20:575–57810.1021/la035961g ↗
25. Petkov V, Peng Y, Williams G, Huang B, Tomalia D, Ren Y (2005) Structure of gold nanoparticles suspended in water studied by X-ray diffraction and computer simulations. Phys Rev B 72:195402-1–195402-810.1103/PhysRevB.72.195402 ↗
26. Pissuwan D, Niidome T, Cortie MB (2011) The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 149:65–7110.1016/j.jconrel.2009.12.006 ↗
27. Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H (2009a) Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5:162–16910.1016/j.nano.2008.11.002 ↗
28. Sadauskas E, Jacobsen NR, Danscher G, Stoltenberg M, Vogel U, Larsen A, Kreyling W, Wallin H (2009b) Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 3:1610.1186/1752-153X-3-16 ↗
29. Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4–2110.1093/toxsci/kfm169 ↗
30. Sun Y, Frenkel AI, White H, Zhang L, Zhu Y, Xu H, Yang JC, Koga T, Zaitsev V, Rafailovich MH, Sokolov JC (2006) Comparison of decanethiolate gold nanoparticles synthesized by one-phase and two-phase methods. J Phys Chem B 110:23022–2303010.1021/jp060432h ↗
31. Sun X, Tabakman SM, Seo WS, Zhang L, Zhang G, Sherlock S, Bai L, Dai H (2009) Separation of nanoparticles in a density gradient: FeCo@C and gold nanocrystals. Angew Chem Int Ed Engl 48:939–94210.1002/anie.200805047 ↗
32. Turkevich J, Stevenson PC, Hillier J (1951) A study of the nucleation and growth processes in the synthesis of collodial gold. Discuss Faraday Soc 11:55–7510.1039/df9511100055 ↗
33. Warheit DB (2008) How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183–18510.1093/toxsci/kfm279 ↗
34. Weitz DA, Huang JS, Lin MY, Sung J (1985) Limits of fractal dimension for irreversible kinetic aggregation of gold colloids. Phys Rev Lett 54:1416–141910.1103/PhysRevLett.54.1416 ↗
35. Xu X, Caswell KK, Tucker E, Kabisatpathy S, Brodhacker KL, Scrivens WA (2007) Size and shape separation of gold nanoparticles with preparative gel electrophoresis. J Chromatogr A 1167:35–4110.1016/j.chroma.2007.07.056 ↗
36. Yogamaler R, Srinivasan R, Vinu A, Ariga K, Bose AC (2009) X-ray peak broadening analysis in ZnO nanoparticles. Solid State Commun 149:1919–192310.1016/j.ssc.2009.07.043 ↗